Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy

As a heterogeneous and aggressive disease, osteosarcoma (OS) faces great challenges to prognosis and individualized treatment. Hence, we explore the role of immune-related genes in predicting prognosis and responsiveness to immunotherapy and targeted therapies in patients with OS based on the immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaofei, Zhao, Zhenrui, Zhao, Yuhao, Song, Zhengdong, Ma, Yao, Wang, Wenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811188/
https://www.ncbi.nlm.nih.gov/pubmed/35127816
http://dx.doi.org/10.3389/fmolb.2021.783915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811188/
https://www.ncbi.nlm.nih.gov/pubmed/35127816
http://dx.doi.org/10.3389/fmolb.2021.783915

Ejemplares similares